Characterizations of Cancer Gene Mutations in Chinese Metastatic Breast Cancer Patients
Background: Breast cancer (BC) is a type of disease with high heterogeneity. Molecular profiling, by revealing the intrinsic nature of its various subtypes, has extensively improved the therapeutic management of BC patients. However, the genomic mutation landscape of Chinese metastatic BC has not be...
Main Authors: | Zhonghua Tao, Ting Li, Zhe Feng, Chang Liu, Yilin Shao, Mingyu Zhu, Chengcheng Gong, Biyun Wang, Jun Cao, Leipin Wang, Yiqun Du, Analyn Lizaso, Bing Li, Jian Zhang, Xichun Hu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-06-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2020.01023/full |
Similar Items
-
Exosomal annexin A6 induces gemcitabine resistance by inhibiting ubiquitination and degradation of EGFR in triple-negative breast cancer
by: Ting Li, et al.
Published: (2021-07-01) -
Apatinib for metastatic breast cancer in non-clinical trial setting: Satisfying efficacy regardless of previous anti-angiogenic treatment
by: Ying Lin, et al.
Published: (2017-06-01) -
Phase II study of Pseudomonas aeruginosa-Mannose-Sensitive hemagglutinin in combination with capecitabine for Her-2-negative metastatic breast cancer pretreated with anthracycline and taxane.
by: Fangfang Lv, et al.
Published: (2015-01-01) -
Phase II study of apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative metastatic breast cancer and clinical implications of monitoring ctDNA
by: Anjie Zhu, et al.
Published: (2021-08-01) -
Real‐world efficacy and potential mechanism of resistance of icotinib in Asian advanced non‐small cell lung cancer with EGFR uncommon mutations: A multi‐center study
by: Lei Lei, et al.
Published: (2020-01-01)